|
|
|
ARCT Forecast
Recent ARCT Price |
|
ARCT Forecast Price |
$26.17 |
+152.20% |
$66.00 |
As of 2024-04-26
Recent ARCT Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
8 |
8 |
8 |
8 |
Buy ratings: |
0 |
0 |
0 |
0 |
Hold ratings: |
0 |
0 |
0 |
0 |
Sell ratings: |
0 |
0 |
0 |
0 |
Strong sell ratings: |
1 |
1 |
1 |
1 |
Average rating: |
1.44 |
1.44 |
1.44 |
1.44 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
For the Arcturus Therapeutics Holdings Inc forecast (traded under symbol ARCT) for one year forward price target at the top of this page, we have presented the average ARCT forecast for forward target price across the 7 analysts covering ARCT, as reported in
data provided by Zacks Investment Research via Quandl.com.
Meanwhile, note that the
median ARCT forecast price target (median being the middle where half of analysts had a higher ARCT forecast and half had a lower ARCT forecast, which is a different metric than the average or mean) was $58.0 as of 2024-04-26, while the
highest ARCT forecast in the analyst group was $140.0, and the lowest ARCT forecast in the analyst group was
$18.0, with a standard deviation of $38.449. Get the latest Zacks research report on ARCT — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Name: |
Arcturus Therapeutics Holdings Inc |
Website: |
www.arcturusrx.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding ARCT: |
30 (see which ones) |
Total Market Value Held by ETFs: |
$139,557,716.31 |
Total Market Capitalization: |
$726,000,000 |
% of Market Cap. Held by ETFs: |
19.22% |
|
|
|
|
Quotes delayed 20 minutes
|
Strong Buy (3.56 out of 4)
64th percentile
|
|
|